Market Cap

Boiron SA Market Capitalization:

€512.4 Million

EUR as of Jan. 1, 2026

US$601.7 Million

business Boiron SA Company Profile

Boiron SA Main Stock Listings

Market Capitalization History of Boiron SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Boiron SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €512.4 M 18.04%
Jan. 1, 2025 €434.1 M -40.03%
Jan. 1, 2024 €723.8 M -16.96%
Jan. 1, 2023 €871.6 M 30.64%
Jan. 1, 2022 €667.2 M 11.21%
Jan. 1, 2021 €600.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Boiron SA Categories

France languages Healthcare languages Drug Manufacturers—Specialty & Generic
France Healthcare France Drug Manufacturers—Specialty & Generic

Stocks & Indices

Boiron SA has the following listings and related stock indices.


Stock: FSX: BON

Stock: Euronext: BOI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.